Global Efavirenz Tablets 麻豆原创 Research Report 2025

Publication ID:

PB506250436

Publication Date:

June 20, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Efavirenz Tablets was valued at US$ 95.2 million in the year 2024 and is projected to reach a revised size of US$ 152 million by 2031, growing at a CAGR of 6.7% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Efavirenz Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Efavirenz is used in combination with other medicines听to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and helps the immune system.
North American market for Efavirenz Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Efavirenz Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Efavirenz Tablets include Huahai Pharmaceutical, DESANO, Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Efavirenz Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Efavirenz Tablets.
The Efavirenz Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Efavirenz Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Efavirenz Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Huahai Pharmaceutical
DESANO
Aurobindo Pharma
Cipla
Hetero
Strides Pharma
Anhui Biochem Bio-Pharmaceutical
Segment by Type
50mg
200mg
600mg
Segment by Application
Adult
Child
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Efavirenz Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Efavirenz Tablets 麻豆原创 Overview
1.1 Product Definition
1.2 Efavirenz Tablets by Type
1.2.1 Global Efavirenz Tablets 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 200mg
1.2.4 600mg
1.3 Efavirenz Tablets by Application
1.3.1 Global Efavirenz Tablets 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Child
1.4 Global Efavirenz Tablets 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Efavirenz Tablets Revenue 2020-2031
1.4.2 Global Efavirenz Tablets Sales 2020-2031
1.4.3 Global Efavirenz Tablets 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Efavirenz Tablets 麻豆原创 Competition by Manufacturers
2.1 Global Efavirenz Tablets Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Efavirenz Tablets Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Efavirenz Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Efavirenz Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Efavirenz Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Efavirenz Tablets, Product Type & Application
2.7 Global Key Manufacturers of Efavirenz Tablets, Date of Enter into This Industry
2.8 Global Efavirenz Tablets 麻豆原创 Competitive Situation and Trends
2.8.1 Global Efavirenz Tablets 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Efavirenz Tablets Players 麻豆原创 Share by Revenue
2.8.3 Global Efavirenz Tablets Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Efavirenz Tablets 麻豆原创 Scenario by Region
3.1 Global Efavirenz Tablets 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Efavirenz Tablets Sales by Region: 2020-2031
3.2.1 Global Efavirenz Tablets Sales by Region: 2020-2025
3.2.2 Global Efavirenz Tablets Sales by Region: 2026-2031
3.3 Global Efavirenz Tablets Revenue by Region: 2020-2031
3.3.1 Global Efavirenz Tablets Revenue by Region: 2020-2025
3.3.2 Global Efavirenz Tablets Revenue by Region: 2026-2031
3.4 North America Efavirenz Tablets 麻豆原创 Facts & Figures by Country
3.4.1 North America Efavirenz Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Efavirenz Tablets Sales by Country (2020-2031)
3.4.3 North America Efavirenz Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Efavirenz Tablets 麻豆原创 Facts & Figures by Country
3.5.1 Europe Efavirenz Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Efavirenz Tablets Sales by Country (2020-2031)
3.5.3 Europe Efavirenz Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Efavirenz Tablets 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Efavirenz Tablets 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Efavirenz Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Efavirenz Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Efavirenz Tablets 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Efavirenz Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Efavirenz Tablets Sales by Country (2020-2031)
3.7.3 Latin America Efavirenz Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Efavirenz Tablets 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Efavirenz Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Efavirenz Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Efavirenz Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Efavirenz Tablets Sales by Type (2020-2031)
4.1.1 Global Efavirenz Tablets Sales by Type (2020-2025)
4.1.2 Global Efavirenz Tablets Sales by Type (2026-2031)
4.1.3 Global Efavirenz Tablets Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Efavirenz Tablets Revenue by Type (2020-2031)
4.2.1 Global Efavirenz Tablets Revenue by Type (2020-2025)
4.2.2 Global Efavirenz Tablets Revenue by Type (2026-2031)
4.2.3 Global Efavirenz Tablets Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Efavirenz Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Efavirenz Tablets Sales by Application (2020-2031)
5.1.1 Global Efavirenz Tablets Sales by Application (2020-2025)
5.1.2 Global Efavirenz Tablets Sales by Application (2026-2031)
5.1.3 Global Efavirenz Tablets Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Efavirenz Tablets Revenue by Application (2020-2031)
5.2.1 Global Efavirenz Tablets Revenue by Application (2020-2025)
5.2.2 Global Efavirenz Tablets Revenue by Application (2026-2031)
5.2.3 Global Efavirenz Tablets Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Efavirenz Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Huahai Pharmaceutical
6.1.1 Huahai Pharmaceutical Company Information
6.1.2 Huahai Pharmaceutical Description and Business Overview
6.1.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
6.1.5 Huahai Pharmaceutical Recent Developments/Updates
6.2 DESANO
6.2.1 DESANO Company Information
6.2.2 DESANO Description and Business Overview
6.2.3 DESANO Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DESANO Efavirenz Tablets Product Portfolio
6.2.5 DESANO Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Efavirenz Tablets Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Hetero
6.5.1 Hetero Company Information
6.5.2 Hetero Description and Business Overview
6.5.3 Hetero Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hetero Efavirenz Tablets Product Portfolio
6.5.5 Hetero Recent Developments/Updates
6.6 Strides Pharma
6.6.1 Strides Pharma Company Information
6.6.2 Strides Pharma Description and Business Overview
6.6.3 Strides Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Strides Pharma Efavirenz Tablets Product Portfolio
6.6.5 Strides Pharma Recent Developments/Updates
6.7 Anhui Biochem Bio-Pharmaceutical
6.7.1 Anhui Biochem Bio-Pharmaceutical Company Information
6.7.2 Anhui Biochem Bio-Pharmaceutical Description and Business Overview
6.7.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
6.7.5 Anhui Biochem Bio-Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Efavirenz Tablets Industry Chain Analysis
7.2 Efavirenz Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Efavirenz Tablets Production Mode & Process Analysis
7.4 Efavirenz Tablets Sales and 麻豆原创ing
7.4.1 Efavirenz Tablets Sales Channels
7.4.2 Efavirenz Tablets Distributors
7.5 Efavirenz Tablets Customer Analysis
8 Efavirenz Tablets 麻豆原创 Dynamics
8.1 Efavirenz Tablets Industry Trends
8.2 Efavirenz Tablets 麻豆原创 Drivers
8.3 Efavirenz Tablets 麻豆原创 Challenges
8.4 Efavirenz Tablets 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Huahai Pharmaceutical
DESANO
Aurobindo Pharma
Cipla
Hetero
Strides Pharma
Anhui Biochem Bio-Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.